Nephros, Inc.
General ticker "NEPH" information:
- Sector: Consumer Discretionary
- Industry: Household Durables
- Capitalization: $30.4M (TTM average)
Nephros, Inc. follows the US Stock Market performance with the rate: 42.5%.
Estimated limits based on current volatility of 5.9%: low 5.05$, high 5.69$
Factors to consider:
- Total employees count: 31 (+14.8%) as of 2023
- Top business risk factors: Net losses and accumulated deficit, Senior management dependency, Supply chain disruptions, Inflation and interest rates, Sales and marketing attrition
- Current price 89.1% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.72$, 3.06$]
- 2025-12-31 to 2026-12-31 estimated range: [1.73$, 3.10$]
Financial Metrics affecting the NEPH estimates:
- Positive: with PPE of -10000.0 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 0.04
- Negative: Operating cash flow per share per price, % of -3.13 <= 0.33
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 76.58 > 63.39
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.66
- Positive: Investing cash flow per share per price, % of -0.32 > -0.66
- Positive: Inventory ratio change, % of 0.80 <= 0.84
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
- Positive: 0 < Industry operating cash flow per share per price (median), % of 0.78
Short-term NEPH quotes
Long-term NEPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $9.97MM | $14.24MM | $14.16MM |
| Operating Expenses | $14.31MM | $15.83MM | $14.16MM |
| Operating Income | $-4.33MM | $-1.59MM | $0.01MM |
| Non-Operating Income | $0.06MM | $0.02MM | $0.08MM |
| Interest Expense | $0.02MM | $0.00MM | $0.00MM |
| R&D Expense | $1.25MM | $0.87MM | $0.91MM |
| Income(Loss) | $-4.28MM | $-1.57MM | $0.09MM |
| Taxes | $0.00MM | $0.00MM | $0.01MM |
| Other Income(Loss) | $-2.83MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-7.38MM | $-1.57MM | $0.07MM |
| Stockholders Equity | $5.59MM | $8.36MM | $8.59MM |
| Inventory | $3.15MM | $2.47MM | $2.62MM |
| Assets | $11.00MM | $11.86MM | $11.21MM |
| Operating Cash Flow | $-3.23MM | $0.83MM | $-0.49MM |
| Capital expenditure | $0.14MM | $0.07MM | $0.06MM |
| Investing Cash Flow | $-0.14MM | $-0.07MM | $-0.05MM |
| Financing Cash Flow | $0.03MM | $-0.08MM | $-0.01MM |
| Earnings Per Share** | $-0.72 | $-0.15 | $0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.